HDAC3 as a novel orchestrator of lipid oxidation in the intestine and potential therapeutic target in obesity.

  • Mariadason, John M (Primary Chief Investigator (PCI))
  • Watt, Matthew (Chief Investigator (CI))
  • Popat, Amirali (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/16 → 31/12/18

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): A$105,000.00